A metabotropic glutamate receptor antagonist reduced cravings for cocaine and alcohol.
Researchers from four countries reported success in the second phase of clinical trials of the metabotropic glutamate receptor antagonist mavoglurant for cocaine use disorder. Participants used it significantly less cocaine…